Ghost Tree Capital, LLC - Q4 2021 holdings

$279 Million is the total value of Ghost Tree Capital, LLC's 47 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was - .

 Value Shares↓ Weighting
IOVA NewIOVANCE BIOTHERAPEUTICS INCcall$9,545,000500,000
+100.0%
3.42%
SRPT NewSAREPTA THERAPEUTICS INC$9,005,000100,000
+100.0%
3.23%
BLU NewBELLUS HEALTH INC NEWput$7,173,000891,000
+100.0%
2.57%
ALNY NewALNYLAM PHARMACEUTICALS INC$5,087,00030,000
+100.0%
1.82%
NewAADI BIOSCIENCE INC$4,830,000200,000
+100.0%
1.73%
KZR NewKEZAR LIFE SCIENCES INC$4,180,000250,000
+100.0%
1.50%
NewPYXIS ONCOLOGY INC$3,236,000295,000
+100.0%
1.16%
DSGN NewDESIGN THERAPEUTICS INC$2,890,000135,000
+100.0%
1.04%
GBT NewGLOBAL BLOOD THERAPEUTICS IN$1,756,00060,000
+100.0%
0.63%
RETA NewREATA PHARMACEUTICALS INCcl a$1,450,00055,000
+100.0%
0.52%
ALDX NewALDEYRA THERAPEUTICS INCcall$1,200,000300,000
+100.0%
0.43%
NewPARDES BIOSCIENCES INC$819,00050,000
+100.0%
0.29%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-02-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MIRATI THERAPEUTICS INC30Q3 20237.3%
ASCENDIS PHARMA A/S - ADR28Q3 202311.8%
BIOCRYST PHARMACEUTICALS INC25Q2 20232.4%
AMICUS THERAPEUTICS INC23Q3 20235.6%
SAREPTA THERAPEUTICS INC22Q3 20239.1%
SPDR SER TR20Q3 202216.9%
IOVANCE BIOTHERAPEUTICS INC18Q2 20235.5%
ROCKET PHARMACEUTICALS INC18Q2 20236.1%
SAGE THERAPEUTICS INC18Q1 20214.8%
IMMUNOMEDICS INC17Q2 20208.7%

View Ghost Tree Capital, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-16
13F-HR2021-11-15

View Ghost Tree Capital, LLC's complete filings history.

Compare quarters

Export Ghost Tree Capital, LLC's holdings